Taylor Susan S, Zhang Ping, Steichen Jon M, Keshwani Malik M, Kornev Alexandr P
Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0654, USA.
Biochim Biophys Acta. 2013 Jul;1834(7):1271-8. doi: 10.1016/j.bbapap.2013.03.007. Epub 2013 Mar 25.
The first protein kinase structure, solved in 1991, revealed the fold that is shared by all members of the eukaryotic protein kinase superfamily and showed how the conserved sequence motifs cluster mostly around the active site. This structure of the PKA catalytic (C) subunit showed also how a single phosphate integrated the entire molecule. Since then the EPKs have become a major drug target, second only to the G-protein coupled receptors. Although PKA provided a mechanistic understanding of catalysis that continues to serve as a prototype for the family, by comparing many active and inactive kinases we subsequently discovered a hydrophobic spine architecture that is a characteristic feature of all active kinases. The ways in which the regulatory spine is dynamically assembled is the defining feature of each protein kinase. Protein kinases have thus evolved to be molecular switches, like the G-proteins, and unlike metabolic enzymes which have evolved to be efficient catalysis. PKA also shows how the dynamic tails surround the core and serve as essential regulatory elements. The phosphorylation sites in PKA, introduced both co- and post-translationally, are very stable. The resulting C-subunit is then packaged as an inhibited holoenzyme with cAMP-binding regulatory (R) subunits so that PKA activity is regulated exclusively by cAMP, not by the dynamic turnover of an activation loop phosphate. We could not understand activation and inhibition without seeing structures of R:C complexes; however, to appreciate the structural uniqueness of each R2:C2 holoenzyme required solving structures of tetrameric holoenzymes. It is these tetrameric holoenzymes that are localized to discrete sites in the cell, typically by A Kinase Anchoring Proteins where they create discrete foci for PKA signaling. Understanding these dynamic macromolecular complexes is the challenge that we now face. This article is part of a Special Issue entitled: Inhibitors of Protein Kinases (2012).
1991年解析出的首个蛋白激酶结构,揭示了真核蛋白激酶超家族所有成员共有的折叠方式,并展示了保守序列基序大多如何聚集在活性位点周围。蛋白激酶A催化(C)亚基的这一结构还展示了单个磷酸基团如何整合整个分子。从那时起,真核蛋白激酶就成为了主要的药物靶点,仅次于G蛋白偶联受体。尽管蛋白激酶A提供了催化作用的机制理解,这一理解至今仍是该家族的原型,但通过比较许多活性和非活性激酶,我们随后发现了一种疏水脊柱结构,这是所有活性激酶的一个特征。调节脊柱动态组装形成的方式是每种蛋白激酶的决定性特征。因此,蛋白激酶已进化为分子开关,类似于G蛋白,与进化为高效催化的代谢酶不同。蛋白激酶A还展示了动态的尾部如何围绕核心并作为重要的调节元件。蛋白激酶A中通过共翻译和翻译后引入的磷酸化位点非常稳定。然后,产生的C亚基与结合cAMP的调节(R)亚基包装成受抑制的全酶,这样蛋白激酶A的活性仅由cAMP调节,而不是由激活环磷酸基团的动态周转调节。如果没有R:C复合物的结构,我们就无法理解激活和抑制;然而,要了解每个R2:C2全酶的结构独特性,则需要解析四聚体全酶的结构。正是这些四聚体全酶定位于细胞中的离散位点,通常是通过A激酶锚定蛋白,在那里它们为蛋白激酶A信号传导创建离散的焦点。理解这些动态大分子复合物是我们现在面临的挑战。本文是名为《蛋白激酶抑制剂》(2012年)的特刊的一部分。